Effect of interferon-gamma on experimental scleroderma induced by bleomycin

Arch Dermatol Res. 2000 Jul;292(7):362-5. doi: 10.1007/s004030000136.

Authors

T Yamamoto¹, S Takagawa, M Kuroda, K Nishioka

Affiliation

¹ Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, Japan.

PMID: 10966061
DOI: 10.1007/s004030000136

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Bleomycin*
Female
Hydroxyproline / antagonists & inhibitors
Hydroxyproline / metabolism
Interferon-gamma / therapeutic use*
Mice
Mice, Inbred BALB C
Pulmonary Fibrosis / chemically induced
Pulmonary Fibrosis / drug therapy
Pulmonary Fibrosis / pathology
Scleroderma, Systemic / chemically induced*
Scleroderma, Systemic / drug therapy*
Scleroderma, Systemic / metabolism
Scleroderma, Systemic / pathology
Skin / metabolism
Skin / pathology

Substances

Bleomycin
Interferon-gamma
Hydroxyproline